Example of Therapeutic Advances in Endocrinology and Metabolism format
Recent searches

Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format Example of Therapeutic Advances in Endocrinology and Metabolism format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Therapeutic Advances in Endocrinology and Metabolism — Template for authors

Publisher: SAGE
Categories Rank Trend in last 3 yrs
Endocrinology, Diabetes and Metabolism #124 of 219 down down by 79 ranks
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 166 Published Papers | 544 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 04/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

SAGE

Quality:  
High
CiteRatio: 5.9
SJR: 1.039
SNIP: 1.036
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 5.0
SJR: 1.229
SNIP: 1.653
open access Open Access

Springer

Quality:  
High
CiteRatio: 6.0
SJR: 1.141
SNIP: 1.158
open access Open Access

Springer

Quality:  
High
CiteRatio: 5.0
SJR: 0.649
SNIP: 1.155

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

3.3

20% from 2019

CiteRatio for Therapeutic Advances in Endocrinology and Metabolism from 2016 - 2020
Year Value
2020 3.3
2019 4.1
2018 6.6
2017 6.4
2016 5.5
graph view Graph view
table view Table view

0.889

2% from 2019

SJR for Therapeutic Advances in Endocrinology and Metabolism from 2016 - 2020
Year Value
2020 0.889
2019 0.872
2018 1.049
2017 1.313
2016 0.995
graph view Graph view
table view Table view

1.363

22% from 2019

SNIP for Therapeutic Advances in Endocrinology and Metabolism from 2016 - 2020
Year Value
2020 1.363
2019 1.737
2018 1.59
2017 1.437
2016 1.459
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 20% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 2% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 22% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Therapeutic Advances in Endocrinology and Metabolism

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

SAGE

Therapeutic Advances in Endocrinology and Metabolism

Approved by publishing and review experts on SciSpace, this template is built as per for Therapeutic Advances in Endocrinology and Metabolism formatting guidelines as mentioned in SAGE author instructions. The current version was created on 04 Jun 2020 and has been used by 352 authors to write and format their manuscripts to this journal.

Endocrinology, Diabetes and Metabolism

Medicine

i
Last updated on
04 Jun 2020
i
ISSN
2042-0188
i
Impact Factor
Low - 0.408
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SageV
i
Citation Type
Numbered (Superscripted)
25
i
Bibliography Example
Blonder GE, Tinkham M and Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B 1982; 25(7): 4515–4532. URL 10.1103/PhysRevB.25.4515.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1177/2042018814559725
GLP-1 receptor agonists: a review of head-to-head clinical studies
Jennifer M. Trujillo1, Wesley Nuffer1, Samuel L. Ellis1

Abstract:

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while having a low risk of hypoglycemia. The GLP-1 RA class has grown in the last decade with several agents available for use in the US and Europe and several mo... Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while having a low risk of hypoglycemia. The GLP-1 RA class has grown in the last decade with several agents available for use in the US and Europe and several more in development. Since the efficacy and tolerability, dosing frequency, administration requirements, and cost may vary between agents within the class, each agent may offer unique advantages and disadvantages. Through a review of phase III clinical programs for exenatide twice daily, exenatide once weekly, liraglutide, albiglutide, lixisenatide, and dulaglutide, eight head-to-head trials have evaluated the safety and efficacy of GLP-1 RA active comparators. The purpose of this review is to provide an analysis of these trials. The GLP-1 RA head-to-head clinical studies have demonstrated that all GLP-1 RA agents are effective therapeutic options at reducing A1C. However, differences exist in terms of magnitude of effect on A1C and weight as well as frequency and severity of adverse effects. read more read less

Topics:

Albiglutide (58%)58% related to the paper, Dulaglutide (55%)55% related to the paper, Lixisenatide (55%)55% related to the paper, Exenatide (54%)54% related to the paper, Tolerability (51%)51% related to the paper
View PDF
236 Citations
open accessOpen access Journal Article DOI: 10.1177/2042018817744513
Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always:

Abstract:

Diabetic foot complications are the most common occurring problems throughout the globe, resulting in devastating economic crises for the patients, families and society. Diabetic foot ulcers (DFUs) have a neuropathic origin with a progressive prevalence rate in developing countries compared with developed countries among diab... Diabetic foot complications are the most common occurring problems throughout the globe, resulting in devastating economic crises for the patients, families and society. Diabetic foot ulcers (DFUs) have a neuropathic origin with a progressive prevalence rate in developing countries compared with developed countries among diabetes mellitus patients. Diabetic patients that are of greatest risk of ulcers may easily be diagnosed with foot examination. Economic burden may be carefully examined. The budget costing must include both the clinical and social impact of the patients. read more read less

Topics:

Diabetic foot (73%)73% related to the paper, Foot (unit) (52%)52% related to the paper
View PDF
182 Citations
open accessOpen access Journal Article DOI: 10.1177/2042018810380214
Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy
Sharon Chan1, Miguel Debono2

Abstract:

Cortisol has one of the most distinct and fascinating circadian rhythms in human physiology This is regulated by the central clock located in the suprachiasmatic nucleus of the hypothalamus It has been suggested that cortisol acts as a secondary messenger between central and peripheral clocks, hence its importance in the sync... Cortisol has one of the most distinct and fascinating circadian rhythms in human physiology This is regulated by the central clock located in the suprachiasmatic nucleus of the hypothalamus It has been suggested that cortisol acts as a secondary messenger between central and peripheral clocks, hence its importance in the synchronization of body circadian rhythms Conventional immediate-release hydrocortisone, either at twice- or thrice-daily doses, is not capable of replicating physiological cortisol circadian rhythm and patients with adrenal insufficiency or congenital adrenal hyperplasia still suffer from a poor quality of life and increased mortality Novel treatments for replacement therapy are therefore essential Proof-of-concept studies using hydrocortisone infusions suggest that the circadian delivery of hydrocortisone may improve biochemical control and life quality in patients lacking cortisol with an impaired cortisol rhythm Recently oral formulations of modified-release hydrocortisone are being developed and it has been shown that it is possible to replicate cortisol circadian rhythm and also achieve better control of morning androgen levels These new drug therapies are promising and potentially offer a more effective treatment with less adverse effects Definite improvements clearly need to be established in future clinical trials read more read less

Topics:

Circadian rhythm (59%)59% related to the paper, Suprachiasmatic nucleus (57%)57% related to the paper, Hydrocortisone (54%)54% related to the paper, Adrenal insufficiency (51%)51% related to the paper
View PDF
174 Citations
open accessOpen access Journal Article DOI: 10.1177/2042018812454322
Licorice abuse: time to send a warning message

Abstract:

Licorice extract has always been recognized as a sweetener and a thirst quencher. Its nutritive value is overrated by many who consume significant amounts and are prone to complications. Glycyrrhetic acid, the active metabolite in licorice, inhibits the enzyme 11-s-hydroxysteroid dehydrogenase enzyme type 2 with a resultant c... Licorice extract has always been recognized as a sweetener and a thirst quencher. Its nutritive value is overrated by many who consume significant amounts and are prone to complications. Glycyrrhetic acid, the active metabolite in licorice, inhibits the enzyme 11-s-hydroxysteroid dehydrogenase enzyme type 2 with a resultant cortisol-induced mineralocorticoid effect and the tendency towards the elevation of sodium and reduction of potassium levels. This aldosterone-like action is the fundamental basis for understanding its health benefits and the wide spectrum of adverse effects. Herein, we present a comprehensive review of licorice along with the reported complications related to excess intake. Despite its apparent use in a few clinical scenarios, the daily consumption of licorice is never justified because its benefits are minor compared to the adverse outcomes of chronic consumption. The review highlights the importance of investigating the dietary habits and herbal remedies which are being used worldwide on cultural and habitual bases rather than reliable scientific evidence. Licorice is a US Food and Drug Administration (FDA) approved food supplement used in many products without precise regulations to prevent toxicity. Increased awareness among the public is required through TV commercials, newspapers, internet sites, magazines and product labels regarding the upper limit of ingestion and health hazards associated with excess intake. We hope that this review will serve as a warning message that should be transmitted from physicians to patients to avoid excessive licorice intake as well as a message to the FDA to start regulating the use of this substance. read more read less
View PDF
172 Citations
open accessOpen access Journal Article DOI: 10.1177/2042018810382481
Endocrine and metabolic emergencies: thyroid storm
Richard Carroll1, Glenn Matfin2

Abstract:

Thyrotoxicosis is a common endocrine condition that may be secondary to a number of underlying processes. Thyroid storm (also known as thyroid or thyrotoxic crisis) represents the severe end of the spectrum of thyrotoxicosis and is characterized by compromised organ function. Whilst rare in the modern era, the mortality rate ... Thyrotoxicosis is a common endocrine condition that may be secondary to a number of underlying processes. Thyroid storm (also known as thyroid or thyrotoxic crisis) represents the severe end of the spectrum of thyrotoxicosis and is characterized by compromised organ function. Whilst rare in the modern era, the mortality rate remains high, and prompt consideration of this endocrine emergency, with specific treatments, can improve outcomes. read more read less

Topics:

Thyroid storm (59%)59% related to the paper, Thyroid (54%)54% related to the paper, Endocrine system (52%)52% related to the paper
View PDF
157 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Therapeutic Advances in Endocrinology and Metabolism.

It automatically formats your research paper to SAGE formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Therapeutic Advances in Endocrinology and Metabolism format uses SageV citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Therapeutic Advances in Endocrinology and Metabolism in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Therapeutic Advances in Endocrinology and Metabolism guidelines and auto format it.

2. Do you follow the Therapeutic Advances in Endocrinology and Metabolism guidelines?

Yes, the template is compliant with the Therapeutic Advances in Endocrinology and Metabolism guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Therapeutic Advances in Endocrinology and Metabolism?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Therapeutic Advances in Endocrinology and Metabolism citation style.

4. Can I use the Therapeutic Advances in Endocrinology and Metabolism templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Therapeutic Advances in Endocrinology and Metabolism.

5. Can I use a manuscript in Therapeutic Advances in Endocrinology and Metabolism that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Therapeutic Advances in Endocrinology and Metabolism that you can download at the end.

6. How long does it usually take you to format my papers in Therapeutic Advances in Endocrinology and Metabolism?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Therapeutic Advances in Endocrinology and Metabolism.

7. Where can I find the template for the Therapeutic Advances in Endocrinology and Metabolism?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Therapeutic Advances in Endocrinology and Metabolism's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Therapeutic Advances in Endocrinology and Metabolism's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Therapeutic Advances in Endocrinology and Metabolism an online tool or is there a desktop version?

SciSpace's Therapeutic Advances in Endocrinology and Metabolism is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Therapeutic Advances in Endocrinology and Metabolism?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Therapeutic Advances in Endocrinology and Metabolism?”

11. What is the output that I would get after using Therapeutic Advances in Endocrinology and Metabolism?

After writing your paper autoformatting in Therapeutic Advances in Endocrinology and Metabolism, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Therapeutic Advances in Endocrinology and Metabolism's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Therapeutic Advances in Endocrinology and Metabolism?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Therapeutic Advances in Endocrinology and Metabolism. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Therapeutic Advances in Endocrinology and Metabolism?

The 5 most common citation types in order of usage for Therapeutic Advances in Endocrinology and Metabolism are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Therapeutic Advances in Endocrinology and Metabolism?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Therapeutic Advances in Endocrinology and Metabolism's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Therapeutic Advances in Endocrinology and Metabolism in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Therapeutic Advances in Endocrinology and Metabolism Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Therapeutic Advances in Endocrinology and Metabolism formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template